{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:30:31Z","timestamp":1792704631041,"version":"4.5.0"},"reference-count":33,"publisher":"Baishideng Publishing Group Inc.","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Crit Care Med"],"abstract":"<jats:p>BACKGROUND<\/jats:p>\n                  <jats:p>Sepsis is a life-threatening condition caused by a dysregulated host response to infection. Peripheral blood mononuclear cells (PBMCs) are critical mediators of the immune response and may exhibit redox imbalance during sepsis. Reactive oxygen species (ROS) are known to influence immune cell signaling, and excessive ROS accumulation may contribute to sepsis-associated immune alterations.<\/jats:p>\n                  <jats:p>AIM<\/jats:p>\n                  <jats:p>To assess intracellular ROS levels in PBMC subsets from septic patients and determine whether norepinephrine (NE) or N-acetylcysteine (NAC) modulate ROS levels following inflammatory stimulation in vitro .<\/jats:p>\n                  <jats:p>METHODS<\/jats:p>\n                  <jats:p>PBMCs were isolated from Department of Emergency patients meeting SEP-1\/SEP-2 sepsis criteria and from healthy controls without signs of infection. Intracellular ROS levels were measured using a total ROS detection assay and analyzed by flow cytometry. PBMCs were also stimulated in vitro  with lipopolysaccharide (LPS) or hydrogen peroxide (H2O2), with or without co-treatment with NE or NAC.<\/jats:p>\n                  <jats:p>RESULTS<\/jats:p>\n                  <jats:p>ROS levels were significantly elevated in CD3+ and CD14+ cells from septic patients compared to controls. In vitro  stimulation of control PBMCs with LPS or H2O2 increased ROS in CD3+ and CD14+ cells, which was attenuated by co-treatment with NE or NAC.<\/jats:p>\n                  <jats:p>CONCLUSION<\/jats:p>\n                  <jats:p>ROS levels are elevated in specific PBMC subsets in sepsis, particularly CD3+ T cells and CD14+ monocytes. NE and NAC reduced ROS accumulation in vitro , supporting their potential role as redox modulators. These findings warrant further mechanistic investigation into immune redox regulation in sepsis.<\/jats:p>","DOI":"10.5492\/wjccm.v14.i4.108638","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:47:36Z","timestamp":1764290856000},"source":"Crossref","is-referenced-by-count":3,"title":["Reactive oxygen species elevations in human immune cell subsets during sepsis are mitigated by norepinephrine and N-acetylcysteine"],"prefix":"10.5492","volume":"14","author":[{"given":"Joby","family":"Thoppil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J David","family":"Farrar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drashya","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaun","family":"Kirby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Mobley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Mark","family":"Courtney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","published-online":{"date-parts":[[2025,12,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.0287"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.45"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2017.165"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/nri3423"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.117.311401"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s00063-020-00673-4"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2012.10.020"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.734229"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12499"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104480"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.632912"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104841"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1271098"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2018.09.004"},{"key":"B15","doi-asserted-by":"crossref","unstructured":"Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES. The sympathetic nerve--an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev 2000; 595-638","DOI":"10.1016\/S0031-6997(24)01470-4"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.14333"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/cells11121979"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0164609"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00347.2013"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.97.10071535"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1177\/0885066617696850"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/0008-8749(92)90205-4"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00097.2011"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2016.08.026"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3390\/cells12091330"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242316610"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.5.2595"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.1045668"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-020-0725-2"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.36"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.5492\/wjccm.v14.i1.101499"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12010175"},{"key":"B33","doi-asserted-by":"crossref","unstructured":"Atkinson MC. The use of N-acetylcysteine in intensive care. Crit Care Resusc 2002; 21-27","DOI":"10.1016\/S1441-2772(23)00714-7"}],"container-title":["World Journal of Critical Care Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.wjgnet.com\/2220-3141\/full\/v14\/i4\/108638.htm","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.wjgnet.com\/2220-3141\/full\/v14\/i4\/108638.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:47:51Z","timestamp":1764290871000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.wjgnet.com\/2220-3141\/full\/v14\/i4\/108638.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,9]]},"references-count":33,"journal-issue":{"issue":"4"},"alternative-id":["108638"],"URL":"https:\/\/doi.org\/10.5492\/wjccm.v14.i4.108638","relation":{},"ISSN":["2220-3141"],"issn-type":[{"value":"2220-3141","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,9]]}}}